Status:
COMPLETED
Active Ageing and Health
Lead Sponsor:
University of Cagliari
Conditions:
Aging
Chronic Disease
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Background: 36% of the Italian population will have more than 65 years in 2050. The European Union has indicated among its priorities to increase research on active aging. Physical activity contrasts ...
Eligibility Criteria
Inclusion
- sedentary (do not practicing regular physical activity, at least 2 times a week, for at least 6 months).
- certificate of fitness for non-competitive physical activity issued by a specialist in Sports Medicine.
Exclusion
- BMI (Body Mass Index)\>35;
- severe cardiovascular disease, such as myocardial infarction in the previous 2 years, aorto-coronary bypass, pacemaker or mechanical valvular prosthesis, aortic stenosis, acute pericarditis, acute myocarditis, aneurysms, angina, arrhythmias, moderate or severe aortic and mitral valve failure, arterial pressure at rest: systolic\> 200 mmHg, or diastolic\> 100 mmHg, pharmacologically non-compensated chronic atrial fibrillation, treatment with oral anticoagulants, thrombophlebitis or pulmonary embolism in the previous 2 years, ongoing moderate/severe anemia (Hb \<10 mg / dL);
- serious problems of autonomous walking, such as fractures of the lower limbs in the previous 2 years, upper limb fractures in the previous 6 months, surgical interventions (non-arthroscopic) in the joints in the previous 2 years, any reason of absolute immobility for more than a week in the previous two months, and for more than two weeks in the previous 6 months, severe osteoporosis, walking problems (eg, use of crutches or stick);
- severe metabolic disorders, such as insulin-treated diabetes mellitus or with HbA1c \> 8, or pharmacologically non-compensated thyreopathies (hyper/hypothyroidism);
- severe neurological conditions that determine the impossibility to carry out the physical activity protocol, such as stroke cerebri in the previous 2 years, or Parkinson's disease;
- severe bronchopulmonary disorders, such as severe bronchial asthma, severe chronic obstructive pulmonary disease, or pulmonary emphysema;
- severe renal disorders and make dialysis;
- severe glaucoma or retinal detachment in the previous 3 months;
- malignant neoplasm in progress, or in the previous 2 years.
Key Trial Info
Start Date :
February 28 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 8 2020
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT03858114
Start Date
February 28 2019
End Date
November 8 2020
Last Update
November 10 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Obesità, AOU Cagliari
Cagliari, Italy, 09100
2
Clinica Dermatologica, AOU Cagliari
Cagliari, Italy, 09100
3
P.O. San Giovanni di Dio, AOU Cagliari
Cagliari, Italy, 09100